C4 Therapeutics, Inc. (CCCC) Revenue 2021–2025
C4 Therapeutics, Inc. (CCCC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$35.9MFY2025 · since FY2021: $45.8M → $35.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.9M | +1.0% |
| FY2024 | $35.6M | +71.4% |
| FY2023 | $20.8M | -33.3% |
| FY2022 | $31.1M | -32.1% |
| FY2021 | $45.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CCCC financial trends
CCCC Net incomeCCCC Net marginCCCC Gross profitCCCC Gross marginCCCC Operating incomeCCCC Operating marginCCCC Operating cash flowCCCC Free cash flowCCCC Capital expendituresCCCC Return on equityCCCC Stock buybacksCCCC Dividends paidCCCC Total assetsCCCC Total liabilitiesCCCC Shareholders’ equityCCCC overview →